Article Information
History
- September 10, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zuleika Aponte Torres1,7 (zullybort{at}gmail.com),
- Sandra Lopez-Leon2,
- Thirumugam Muthuvel3,
- Subha Manivannan4,
- Krutika Srivastava5 and
- Marco Pavesi6
- 1 Aponte Epidemiology Consultancy;
- 2 Novartis Pharmaceuticals Corporation;
- 3 Independent Researcher;
- 4 Subhag HealthTech Pvt. Ltd;
- 5 Massachusetts College of Pharmacy and Health Science;
- 6 Data Center, European Foundation for the study of Chronic Liver Failure (EF-CLIF)
- ↵* Corresponding author; email: zullybort{at}gmail.com
Posted September 10, 2020.
Safety and Efficacy of Antiviral Drugs for the Treatment of Patients with SARS-CoV-2 Infection: A Systematic Review and Meta-analyses
